Company Valuation: West Pharmaceutical Services, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 34,744 17,424 26,053 23,723 19,795 25,688 - -
Change - -49.85% 49.53% -8.95% -16.56% 29.77% - -
Enterprise Value (EV) 1 34,744 16,738 25,406 23,441 19,206 25,185 24,714 24,346
Change - -51.82% 51.78% -7.74% -18.07% 31.13% -1.87% -1.49%
P/E 54.1x 30.4x 44.7x 49x 40.5x 42.6x 37x 33.1x
PBR 14.9x 6.5x 8.98x 8.83x 5.95x 8.13x 7.17x 6.38x
PEG - -2.8x 23.04x -3.2x 27.09x 1.6x 2.5x 2.8x
Capitalization / Revenue 12.3x 6.04x 8.83x 8.2x 6.44x 7.61x 7.16x 6.66x
EV / Revenue 12.3x 5.8x 8.61x 8.1x 6.25x 7.46x 6.89x 6.31x
EV / EBITDA 39.3x 19x 30.7x 32.2x 24.2x 26.8x 23.7x 20.9x
EV / EBIT 45.6x 22x 36.8x 40.9x 30.9x 33.3x 29.1x 25.4x
EV / FCF 105x 38.1x 61.3x 84.8x 41x 58.5x 43.5x 33.6x
FCF Yield 0.95% 2.63% 1.63% 1.18% 2.44% 1.71% 2.3% 2.98%
Dividend per Share 2 0.69 0.74 0.78 0.82 0.85 0.9025 0.9729 1.118
Rate of return 0.15% 0.31% 0.22% 0.25% 0.31% 0.25% 0.27% 0.31%
EPS 2 8.67 7.73 7.88 6.69 6.79 8.575 9.865 11.04
Distribution rate 7.96% 9.57% 9.9% 12.3% 12.5% 10.5% 9.86% 10.1%
Net sales 1 2,832 2,887 2,950 2,893 3,074 3,375 3,587 3,860
EBITDA 1 884.7 882.6 827.9 728.2 793.8 939.3 1,041 1,162
EBIT 1 762.4 762 690.6 572.8 622.4 757.1 848.8 957
Net income 1 661.8 585.9 593.4 492.7 493.7 621.5 710.2 798.6
Net Debt 1 - -685.4 -647.1 -282 -588.5 -503.3 -973.5 -1,342
Reference price 2 469.01 235.35 352.12 327.56 275.14 365.01 365.01 365.01
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 70,376 - -
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 12/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
42.57x7.46x26.81x0.25% 25.69B
27.39x3.81x14.72x2.66% 167B
18.26x3.37x12.05x3.26% 111B
21.23x4.18x14.6x1.32% 105B
25.57x2.51x10.15x2.82% 74.82B
16.96x0.2x12.44x0.77% 59.11B
29.74x7.35x19.01x1.35% 51.8B
34.32x3.34x11.44x2.2% 48.5B
35.06x8.71x24.52x-.--% 40.79B
34.65x6.08x19.07x-.--% 32.54B
Average 28.58x 4.70x 16.48x 1.46% 71.58B
Weighted average by Cap. 25.98x 4.10x 14.90x 1.93%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. WST Stock
  4. Valuation West Pharmaceutical Services, Inc.